Profit before payment of interest, taxes and amortization: pfizer.com (PFE)

Graphic logo of pfizer.com (PFE)

Pfizer Inc. (PFE) maintains high margins driven by efficient global logistics and cold chain management, as reflected in the company's EBITDA. The 23101.44 level captures the current operational resilience of a business supported by an extensive clinical trial network. However, declining vaccine demand and debt burdens create risks that the behemoth is mitigating through expansion into the oncology sector.

Pfizer Inc. (PFE) - Operating profit EBITDA from 11/23/2025 to 11/10/2026

Pfizer (PFE) - metric breakdowns and financial figures

- market value and analyst target forecast:
Market Price Pfizer Corp|PFE - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Pfizer|PFE - Enterprise Value
- business book valuation details:
Equity per Share Pfizer|PFE - Book Capitalization|Market Capitalization to Book Value pfizer.com|PFE - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Ratio Pfizer Inc.|PFE - Long-Term Debt to Capital|Short-Term Indebtedness to Equity Pfizer Inc|PFE - Company Debts|Debts to Book Capitalization Ratio Pfizer|PFE - Company Long-Term Debts|Current Liabilities Pfizer|Interim Coverage Ratio pfizer.com
- earnings and valuation multiples indicators:
PFE - Net Income|Forward Earnings Pfizer Inc.|PFE - P/E Multiple|Projected Price to Earnings Ratio pfizer.com|PFE - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Pfizer|PFE - Operating profit before deduction of amortization|Earnings per share for the trailing year Pfizer|PFE - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months pfizer.com|PFE - Earnings per share growth in current year|Projected earnings per share growth rate for next year Pfizer Inc.
Analysis of all company metrics:Pfizer Corp, PFE
Flagship merchandise of Pfizer

Investors must assess the cash flow resilience of Pfizer Inc. (PFE) amid intense pressure from generics and R&D expenditures. An analysis of operational efficiency reveals whether the company possesses sufficient resources to acquire biotech startups. The EBITDA timeline demonstrates the actual cash inflow before taxes and depreciation, eliminating accounting distortions. This indicator measures the business's net ability to generate cash. The stability of this metric confirms the reliability of the asset's fundamental value.

Who Pfizer Inc. competes with

Eli Lilly and Co. (LLY) - Profit before interest, taxes and amortization|ABBV - Profit before payment of interest, taxes and amortization|AZN: Profit before payment of interest, taxes and amortization|NVS: Operating profit EBITDA|Operating profit before amortization MRK|NVO (Novo Nordisk Inc.) - Operating profit EBITDA|Amgen Inc (AMGN) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Sanofi (SNY)|bms.com - Operating profit before amortization|Operating profit EBITDA GSK (GlaxoSmithKline)|Operating profit before depreciation charges Takeda Pharmaceutical Company|TEVA - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization RDY|VTRS: Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization ROIV (roivant.com)|ZLAB (Zai Lab) - Operating profit EBITDA|Bausch Health Companies Inc. (BHC) - Operating income before deduction of amortization|Operating profit before deduction of amortization COSM (Cosmos Holdings)